Brasil | Article

What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?

dc.creatorTorres, Thiago S.
dc.creatorRolla, Valéria C.
dc.date2023-02-11T01:36:12Z
dc.date2023-02-11T01:36:12Z
dc.date2007
dc.date.accessioned2023-09-26T20:11:46Z
dc.date.available2023-09-26T20:11:46Z
dc.identifierTORRES, Thiago S. ; ROLLA, Valéria C. What is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir? The international Journal of Tuberculosis and Lung Disease, v. 11, n. 8, p. 933-934, 2007.
dc.identifier1027-3719
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/57017
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8851055
dc.formatapplication/pdf
dc.languageeng
dc.publisherIngenta Connect
dc.rightsopen access
dc.subjectTuberculosis
dc.subjectDisease
dc.subjectTB-HIV
dc.subjectHAART
dc.subjectRifampicin
dc.titleWhat is the best strategy for treating TB-HIV co-infected patients with HAART and rifampicin without saquinavir?
dc.typeArticle


Este ítem pertenece a la siguiente institución